secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2026-05-22T20:01:45+00:00
Accession:  0001193125-26-236820
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics delays Karen Vousden board appointment to later 2026; board size set to five
--------------------------------------------------------------------------------

- Karen Vousden delays board appointment to later 2026 due to personal reasons; Board to consider appointment in Q3 or Q4 2026.
- If stockholder matters pass at June 10 annual meeting, Bob Holmen to become chair of Nominating and Corporate Governance Committee on June 12.
- Board size approved at five directors effective upon reconstitution.
- Annual meeting scheduled June 10, 2026; definitive proxy filed April 27.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312526236820/0001193125-26-236820-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312526236820/d900837d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-236820

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer